Selexipag for the treatment of children with pulmonary arterial hypertension: First multicenter experience in drug safety and efficacy

Title
Selexipag for the treatment of children with pulmonary arterial hypertension: First multicenter experience in drug safety and efficacy
Authors
Keywords
prostacyclin, IP receptor agonist, pulmonary hypertension, pulmonary vascular disease, heart failure, right ventricle
Journal
Publisher
Elsevier BV
Online
2020-04-07
DOI
10.1016/j.healun.2020.03.029

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started